Subjects will be randomized 1:1 Radio Frequency (RF) Ablation arm vs Control arm; this is an open-label trial. Subjects in the the RF Ablation arm will receive the Intracept System procedure to treat one or two motion segments. Subjects in the Control arm will continue on non-surgical management therapies to treat their chronic low back pain (CLBP) and will be offered optional crossover after 12 months of follow-up.